Biotech

All Articles

Vertex, beaten by AATD again, falls 2 assets on dispose of heap

.Vertex's attempt to deal with an uncommon hereditary health condition has hit an additional setback...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter earnings file had not been except large news. The company welcomed a t...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism case

.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell therapy, pumping ...

James Wilson leaving Penn to release pair of brand-new biotechs

.After greater than thirty years, gene therapy pioneer James Wilson M.D., Ph.D., is actually leaving...

3 biotechs attempt to trump the summertime warm through losing staff

.As biotechs try to turn a fresh page in August, a minimum of three business have actually shed pers...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Pro venture capital organization venBio has actually lifted an additional half a billion bucks to a...

Otsuka spends $800M for Jnana as well as its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 thousand so the Japanese bi...

FibroGen lays off 75% of US team as asset flunks 2 more trials

.FibroGen is radically reorganizing its own service, giving up 75% of its own U.S. team and also qui...

Tracon winds down full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has made a decision to wind down operations full weeks after an injectable i...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...